Klebsiella pneumoniae, a bacterium found in the gut, may reach the brain and affect Alzheimer's disease progression, research ...

As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a ...

The results in Alzheimer's come a few months after Lexeo also reported encouraging data with its gene therapy for ...

A new blood test that can detect Alzheimer's disease in mere minutes has the potential to revolutionise treatment.

Alzheimer's disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University in ...

Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...

Roche later made changes to the trial design, although the company said overall results support further testing.

Braisted said wandering is a risk for every person living with Alzheimer's or other dementias. "So, it's really important to ...

For adults aged 65 years and older with Alzheimer's disease, the emergency department visit rate was 36.1 visits per 1,000 ...